Mark Hancock, an officer and director of PACS Group, Inc., filed a Form 144 notice on October 29, 2026, disclosing a proposed sale of 4,280 shares of PACS Group common stock on the NYSE.

Key Highlights

  • Proposed sale: Mark Hancock intends to sell 4,280 shares of PACS Group, Inc. common stock, with an aggregate market value of $214,101.01, according to the filing.
  • Approximate sale date: The filing lists October 29, 2026 as the approximate date of sale, executed through Citigroup Global Markets Inc.
  • Original acquisition: The shares to be sold were acquired on March 1, 2023, as part of shares acquired at formation of the issuer, for cash consideration, from the issuer itself, totaling 54,626,199 shares at that time.
  • Prior three-month sales: Hancock sold 144,318 shares on September 14, 2026, for gross proceeds of $6,432,859.40; 155,682 shares on September 15, 2026, for gross proceeds of $6,612,032.49; and 9,024 shares on October 28, 2026, for gross proceeds of $452,120.45.
  • Rule 10b5-1 plan: The filing indicates a written trading plan was adopted on March 3, 2026.
  • Shares outstanding: The filing states 158,022,308 shares of common stock are outstanding.

PACS Group Officer and Director Hancock Files Proposed Share Sale Notice

According to the Form 144 filing submitted on October 29, 2026, Mark Hancock, who is identified as both an officer and a director of PACS Group, Inc. (NYSE:PACS), has provided notice of a proposed sale of 4,280 shares of the company's common stock. The aggregate market value of the shares proposed to be sold is listed as $214,101.01. The sale is to be conducted through Citigroup Global Markets Inc., located at 388 Greenwich Street, New York, NY 10013, on the NYSE.

The filing discloses that the securities to be sold were originally acquired on March 1, 2023, described as "shares acquired at formation of the issuer," with the issuer itself named as the party from whom they were acquired. The nature of payment is listed as cash, and the total amount of securities acquired in that transaction was 54,626,199 shares. The filing also indicates that Hancock adopted a written trading plan pursuant to Rule 10b5-1 on March 3, 2026.

The filing further reports that Hancock sold 144,318 shares on September 14, 2026, generating gross proceeds of $6,432,859.40, and 155,682 shares on September 15, 2026, generating gross proceeds of $6,612,032.49. An additional 9,024 shares were sold on October 28, 2026, for gross proceeds of $452,120.45. These transactions are reported as sales during the past three months for aggregation purposes under Rule 144.

What Was Disclosed

Mark Hancock, an officer and director of PACS Group, Inc., filed a Form 144 notice proposing to sell 4,280 shares of common stock valued at $214,101.01, relying on a Rule 10b5-1 plan adopted March 3, 2026, with the NYSE as the named securities exchange.